| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Primary Health Care | 23 | 2025 | 775 | 3.600 |
Why?
|
| Substance-Related Disorders | 7 | 2024 | 496 | 3.140 |
Why?
|
| Family Practice | 11 | 2010 | 84 | 1.490 |
Why?
|
| Opioid-Related Disorders | 4 | 2025 | 354 | 1.390 |
Why?
|
| Alcohol Drinking | 7 | 2017 | 341 | 1.350 |
Why?
|
| Complementary Therapies | 5 | 2014 | 45 | 1.340 |
Why?
|
| Anti-Bacterial Agents | 19 | 2025 | 2596 | 1.340 |
Why?
|
| Urinary Tract Infections | 7 | 2025 | 342 | 1.310 |
Why?
|
| Vulnerable Populations | 3 | 2017 | 151 | 1.290 |
Why?
|
| United States | 48 | 2025 | 12072 | 1.270 |
Why?
|
| Alcohol-Related Disorders | 4 | 2018 | 35 | 1.170 |
Why?
|
| Patient Readmission | 4 | 2021 | 442 | 1.170 |
Why?
|
| Professional-Patient Relations | 3 | 2025 | 92 | 1.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 11 | 2024 | 919 | 1.130 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 3 | 2014 | 13 | 1.130 |
Why?
|
| Adult | 57 | 2025 | 31282 | 1.030 |
Why?
|
| Intention | 2 | 2024 | 105 | 0.980 |
Why?
|
| Humans | 119 | 2026 | 131163 | 0.940 |
Why?
|
| Communication | 4 | 2025 | 543 | 0.910 |
Why?
|
| Vital Signs | 1 | 2025 | 24 | 0.910 |
Why?
|
| Health Promotion | 6 | 2016 | 422 | 0.870 |
Why?
|
| Health Behavior | 5 | 2023 | 387 | 0.860 |
Why?
|
| Mass Screening | 4 | 2024 | 822 | 0.840 |
Why?
|
| Nonprescription Drugs | 3 | 2025 | 59 | 0.820 |
Why?
|
| Buprenorphine | 3 | 2025 | 128 | 0.800 |
Why?
|
| Pediatric Obesity | 5 | 2018 | 419 | 0.800 |
Why?
|
| Female | 71 | 2025 | 70963 | 0.770 |
Why?
|
| Respiratory Tract Infections | 4 | 2013 | 298 | 0.760 |
Why?
|
| Papillomavirus Vaccines | 1 | 2024 | 113 | 0.740 |
Why?
|
| Phobic Disorders | 1 | 2022 | 40 | 0.740 |
Why?
|
| Panic Disorder | 1 | 2022 | 53 | 0.730 |
Why?
|
| Spinal Cord Injuries | 1 | 2025 | 273 | 0.720 |
Why?
|
| Yoga | 1 | 2021 | 13 | 0.690 |
Why?
|
| Meditation | 1 | 2021 | 21 | 0.680 |
Why?
|
| Tobacco Products | 1 | 2022 | 60 | 0.670 |
Why?
|
| Inpatients | 3 | 2020 | 562 | 0.670 |
Why?
|
| Middle Aged | 35 | 2025 | 28601 | 0.670 |
Why?
|
| Male | 56 | 2025 | 64957 | 0.660 |
Why?
|
| Language | 2 | 2023 | 219 | 0.650 |
Why?
|
| Treatment Refusal | 2 | 2020 | 80 | 0.640 |
Why?
|
| Smoking | 4 | 2022 | 932 | 0.630 |
Why?
|
| Amphetamines | 1 | 2020 | 8 | 0.630 |
Why?
|
| Opiate Alkaloids | 1 | 2020 | 4 | 0.630 |
Why?
|
| Cross-Sectional Studies | 17 | 2025 | 3829 | 0.630 |
Why?
|
| Family Health | 2 | 2018 | 240 | 0.620 |
Why?
|
| Patient Discharge | 3 | 2020 | 514 | 0.610 |
Why?
|
| Internship and Residency | 9 | 2025 | 1223 | 0.600 |
Why?
|
| Papillomavirus Infections | 1 | 2024 | 394 | 0.590 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2019 | 37 | 0.580 |
Why?
|
| Tobacco Use Disorder | 1 | 2020 | 87 | 0.580 |
Why?
|
| Drug Prescriptions | 2 | 2018 | 237 | 0.580 |
Why?
|
| Hospitalization | 6 | 2021 | 1950 | 0.580 |
Why?
|
| Primary Prevention | 2 | 2011 | 183 | 0.560 |
Why?
|
| Cocaine | 1 | 2020 | 211 | 0.560 |
Why?
|
| Health Care Costs | 3 | 2016 | 407 | 0.540 |
Why?
|
| Postpartum Period | 1 | 2020 | 245 | 0.540 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2017 | 1459 | 0.540 |
Why?
|
| Young Adult | 18 | 2024 | 10103 | 0.530 |
Why?
|
| Adjustment Disorders | 1 | 2017 | 5 | 0.530 |
Why?
|
| Health Transition | 1 | 2017 | 10 | 0.530 |
Why?
|
| Depression | 4 | 2024 | 1320 | 0.530 |
Why?
|
| Social Stigma | 1 | 2018 | 82 | 0.530 |
Why?
|
| Surveys and Questionnaires | 13 | 2026 | 4066 | 0.520 |
Why?
|
| Databases, Factual | 2 | 2020 | 1240 | 0.520 |
Why?
|
| Binge Drinking | 1 | 2017 | 11 | 0.520 |
Why?
|
| Adolescent | 23 | 2024 | 20987 | 0.510 |
Why?
|
| Cocaine-Related Disorders | 1 | 2019 | 205 | 0.510 |
Why?
|
| Counseling | 3 | 2020 | 238 | 0.510 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2018 | 63 | 0.500 |
Why?
|
| Community Networks | 2 | 2013 | 30 | 0.480 |
Why?
|
| Pregnancy Complications | 2 | 2020 | 567 | 0.480 |
Why?
|
| Cystitis | 3 | 2023 | 47 | 0.480 |
Why?
|
| Diabetes Complications | 1 | 2017 | 197 | 0.470 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 621 | 0.460 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2025 | 789 | 0.460 |
Why?
|
| Aged | 22 | 2025 | 21025 | 0.460 |
Why?
|
| Hospital Mortality | 2 | 2021 | 1064 | 0.450 |
Why?
|
| Urinalysis | 2 | 2025 | 72 | 0.440 |
Why?
|
| Telemedicine | 2 | 2023 | 526 | 0.440 |
Why?
|
| Prevalence | 9 | 2025 | 2701 | 0.430 |
Why?
|
| Personality Disorders | 1 | 2017 | 176 | 0.420 |
Why?
|
| Low Back Pain | 1 | 2014 | 42 | 0.410 |
Why?
|
| Pregnancy | 16 | 2024 | 7512 | 0.410 |
Why?
|
| Nursing Staff | 1 | 2013 | 12 | 0.410 |
Why?
|
| Education, Nursing, Continuing | 1 | 2013 | 20 | 0.410 |
Why?
|
| Depressive Disorder | 1 | 2017 | 460 | 0.400 |
Why?
|
| Education, Nursing, Baccalaureate | 1 | 2013 | 18 | 0.400 |
Why?
|
| Family | 2 | 2016 | 589 | 0.400 |
Why?
|
| Psychotherapy, Brief | 1 | 2014 | 53 | 0.400 |
Why?
|
| Healthcare Disparities | 2 | 2016 | 523 | 0.390 |
Why?
|
| Exercise | 3 | 2016 | 892 | 0.390 |
Why?
|
| Oral Health | 1 | 2013 | 28 | 0.390 |
Why?
|
| Athletic Performance | 1 | 2013 | 12 | 0.380 |
Why?
|
| Preventive Health Services | 2 | 2015 | 59 | 0.380 |
Why?
|
| Dehydration | 1 | 2013 | 40 | 0.380 |
Why?
|
| Physicians, Primary Care | 2 | 2024 | 100 | 0.380 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 236 | 0.380 |
Why?
|
| Retrospective Studies | 18 | 2024 | 17753 | 0.380 |
Why?
|
| Community-Based Participatory Research | 1 | 2013 | 65 | 0.380 |
Why?
|
| Clostridium Infections | 1 | 2016 | 250 | 0.370 |
Why?
|
| Diet | 2 | 2017 | 1121 | 0.370 |
Why?
|
| Fluid Therapy | 1 | 2013 | 141 | 0.360 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 464 | 0.360 |
Why?
|
| Health Services Accessibility | 4 | 2026 | 712 | 0.360 |
Why?
|
| Texas | 6 | 2026 | 3686 | 0.350 |
Why?
|
| Evidence-Based Medicine | 2 | 2014 | 645 | 0.340 |
Why?
|
| Self Care | 1 | 2013 | 231 | 0.340 |
Why?
|
| Croup | 1 | 2011 | 14 | 0.340 |
Why?
|
| Lepidoptera | 1 | 2011 | 3 | 0.340 |
Why?
|
| Foot Dermatoses | 1 | 2011 | 7 | 0.330 |
Why?
|
| Physicians, Family | 2 | 2002 | 37 | 0.330 |
Why?
|
| Health Status Disparities | 3 | 2025 | 282 | 0.330 |
Why?
|
| Managed Care Programs | 3 | 1999 | 54 | 0.330 |
Why?
|
| Obesity | 4 | 2022 | 2426 | 0.320 |
Why?
|
| Behavior Therapy | 1 | 2013 | 273 | 0.320 |
Why?
|
| Insect Bites and Stings | 1 | 2011 | 41 | 0.320 |
Why?
|
| Genital Diseases, Female | 1 | 2010 | 31 | 0.310 |
Why?
|
| Travel | 1 | 2011 | 117 | 0.310 |
Why?
|
| Universities | 3 | 2022 | 125 | 0.300 |
Why?
|
| Diabetes Mellitus | 4 | 2024 | 889 | 0.300 |
Why?
|
| Clinical Clerkship | 1 | 2010 | 71 | 0.290 |
Why?
|
| Alcoholism | 2 | 2025 | 244 | 0.290 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2017 | 895 | 0.290 |
Why?
|
| Bacteriuria | 2 | 2022 | 80 | 0.280 |
Why?
|
| Risk Factors | 12 | 2025 | 11074 | 0.270 |
Why?
|
| Curriculum | 5 | 2013 | 798 | 0.270 |
Why?
|
| Patient Education as Topic | 4 | 2025 | 464 | 0.260 |
Why?
|
| Narcotic Antagonists | 2 | 2018 | 112 | 0.260 |
Why?
|
| Clinical Competence | 2 | 2016 | 1050 | 0.260 |
Why?
|
| Peptic Ulcer | 2 | 1999 | 151 | 0.260 |
Why?
|
| Breast Neoplasms | 3 | 2018 | 2602 | 0.260 |
Why?
|
| Fibromyalgia | 1 | 2007 | 20 | 0.260 |
Why?
|
| Aged, 80 and over | 8 | 2021 | 6797 | 0.250 |
Why?
|
| Drug Utilization | 5 | 2016 | 164 | 0.250 |
Why?
|
| MELAS Syndrome | 1 | 2007 | 39 | 0.240 |
Why?
|
| Socioeconomic Factors | 4 | 2017 | 915 | 0.240 |
Why?
|
| Floods | 1 | 2026 | 21 | 0.230 |
Why?
|
| Phytotherapy | 2 | 2010 | 48 | 0.230 |
Why?
|
| Public Health | 2 | 2022 | 269 | 0.230 |
Why?
|
| Body Mass Index | 4 | 2017 | 1717 | 0.230 |
Why?
|
| Stress, Psychological | 2 | 2024 | 536 | 0.230 |
Why?
|
| Program Evaluation | 2 | 2018 | 447 | 0.230 |
Why?
|
| Anxiety Disorders | 2 | 2022 | 731 | 0.230 |
Why?
|
| Quadriplegia | 1 | 2025 | 34 | 0.230 |
Why?
|
| Inappropriate Prescribing | 1 | 2025 | 40 | 0.230 |
Why?
|
| Unnecessary Procedures | 1 | 2025 | 61 | 0.220 |
Why?
|
| DNA, Mitochondrial | 1 | 2007 | 233 | 0.220 |
Why?
|
| Guidelines as Topic | 2 | 2004 | 198 | 0.220 |
Why?
|
| Evidence-Based Practice | 2 | 2018 | 115 | 0.220 |
Why?
|
| Tennessee | 2 | 2016 | 51 | 0.220 |
Why?
|
| Paraplegia | 1 | 2025 | 84 | 0.220 |
Why?
|
| Attitude of Health Personnel | 2 | 2024 | 707 | 0.220 |
Why?
|
| Child | 12 | 2024 | 26341 | 0.220 |
Why?
|
| Opiate Substitution Treatment | 1 | 2025 | 66 | 0.220 |
Why?
|
| Length of Stay | 3 | 2020 | 1421 | 0.210 |
Why?
|
| Louisiana | 6 | 2002 | 137 | 0.210 |
Why?
|
| Gammaproteobacteria | 1 | 2024 | 14 | 0.210 |
Why?
|
| Educational Status | 2 | 2025 | 279 | 0.210 |
Why?
|
| Aging | 1 | 2011 | 1242 | 0.200 |
Why?
|
| Infant, Newborn | 8 | 2022 | 8635 | 0.200 |
Why?
|
| Community Health Services | 2 | 2015 | 86 | 0.200 |
Why?
|
| Equipment and Supplies | 1 | 2004 | 27 | 0.200 |
Why?
|
| Drug Industry | 1 | 2004 | 49 | 0.200 |
Why?
|
| Gift Giving | 1 | 2004 | 18 | 0.200 |
Why?
|
| Electronic Mail | 1 | 2024 | 41 | 0.200 |
Why?
|
| Sex Factors | 6 | 2023 | 1356 | 0.200 |
Why?
|
| Fatigue | 1 | 2024 | 191 | 0.200 |
Why?
|
| Mortality | 3 | 2023 | 264 | 0.200 |
Why?
|
| Diagnosis, Differential | 5 | 2011 | 1882 | 0.200 |
Why?
|
| Conflict of Interest | 1 | 2004 | 66 | 0.200 |
Why?
|
| Education, Distance | 1 | 2024 | 69 | 0.200 |
Why?
|
| Seat Belts | 2 | 2013 | 24 | 0.190 |
Why?
|
| Body Weight | 2 | 2018 | 987 | 0.190 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2011 | 333 | 0.190 |
Why?
|
| Quarantine | 1 | 2023 | 19 | 0.190 |
Why?
|
| Education, Medical, Continuing | 1 | 2004 | 132 | 0.190 |
Why?
|
| Institutional Practice | 1 | 2002 | 4 | 0.190 |
Why?
|
| Dyspnea | 1 | 2003 | 159 | 0.180 |
Why?
|
| Hospitals, Community | 1 | 2002 | 51 | 0.180 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 1545 | 0.180 |
Why?
|
| Papanicolaou Test | 1 | 2022 | 35 | 0.180 |
Why?
|
| Global Health | 2 | 2017 | 626 | 0.180 |
Why?
|
| Physician-Patient Relations | 1 | 2025 | 441 | 0.180 |
Why?
|
| Risk-Taking | 2 | 2013 | 96 | 0.180 |
Why?
|
| Pandemics | 3 | 2024 | 1118 | 0.170 |
Why?
|
| Cardiomyopathy, Alcoholic | 1 | 2021 | 4 | 0.170 |
Why?
|
| Age Factors | 6 | 2021 | 2825 | 0.170 |
Why?
|
| Health Surveys | 2 | 2025 | 261 | 0.170 |
Why?
|
| Ethics, Medical | 1 | 2004 | 400 | 0.170 |
Why?
|
| Pregnancy Outcome | 3 | 2015 | 623 | 0.160 |
Why?
|
| Early Detection of Cancer | 2 | 2022 | 421 | 0.160 |
Why?
|
| Plants, Medicinal | 1 | 2000 | 25 | 0.160 |
Why?
|
| Health Status | 3 | 2015 | 378 | 0.160 |
Why?
|
| Academic Medical Centers | 1 | 2002 | 321 | 0.160 |
Why?
|
| Patient Dropouts | 1 | 2020 | 50 | 0.160 |
Why?
|
| Neoplasms | 3 | 2021 | 3016 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 555 | 0.160 |
Why?
|
| Escherichia coli Infections | 1 | 2022 | 198 | 0.150 |
Why?
|
| Asphyxia | 1 | 2019 | 15 | 0.150 |
Why?
|
| Nutrition Surveys | 1 | 2022 | 338 | 0.150 |
Why?
|
| Tobacco Use | 1 | 2020 | 29 | 0.150 |
Why?
|
| Pain Measurement | 2 | 2014 | 353 | 0.150 |
Why?
|
| Health Personnel | 1 | 2024 | 541 | 0.150 |
Why?
|
| Sudden Infant Death | 1 | 2019 | 36 | 0.150 |
Why?
|
| Self Medication | 1 | 2019 | 20 | 0.150 |
Why?
|
| Behavioral Medicine | 1 | 1999 | 11 | 0.150 |
Why?
|
| Multivariate Analysis | 4 | 2016 | 1378 | 0.150 |
Why?
|
| Medical Staff, Hospital | 1 | 1999 | 91 | 0.150 |
Why?
|
| Acute Disease | 4 | 2017 | 1153 | 0.150 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 3 | 2024 | 45 | 0.140 |
Why?
|
| Mentoring | 1 | 2020 | 85 | 0.140 |
Why?
|
| Health Care Surveys | 2 | 2015 | 276 | 0.140 |
Why?
|
| Child, Preschool | 8 | 2018 | 15110 | 0.140 |
Why?
|
| Ciprofloxacin | 3 | 2024 | 66 | 0.140 |
Why?
|
| Multimorbidity | 1 | 2018 | 23 | 0.140 |
Why?
|
| Glaucoma | 1 | 1999 | 73 | 0.140 |
Why?
|
| Helicobacter pylori | 2 | 1999 | 1373 | 0.140 |
Why?
|
| Students | 1 | 2001 | 250 | 0.140 |
Why?
|
| Helicobacter Infections | 2 | 1999 | 1313 | 0.140 |
Why?
|
| Infant Mortality | 1 | 2019 | 183 | 0.140 |
Why?
|
| Vaccination | 1 | 2024 | 1060 | 0.140 |
Why?
|
| Homicide | 1 | 2018 | 34 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2025 | 3359 | 0.140 |
Why?
|
| Leadership | 1 | 2021 | 255 | 0.140 |
Why?
|
| Hypercholesterolemia | 1 | 2000 | 230 | 0.140 |
Why?
|
| Hospitals | 2 | 2021 | 435 | 0.140 |
Why?
|
| Population Surveillance | 3 | 2019 | 396 | 0.130 |
Why?
|
| Anxiety | 2 | 2022 | 1014 | 0.130 |
Why?
|
| Culture | 1 | 2018 | 70 | 0.130 |
Why?
|
| Dysthymic Disorder | 1 | 2017 | 7 | 0.130 |
Why?
|
| Multicenter Studies as Topic | 1 | 2018 | 294 | 0.130 |
Why?
|
| Clinical Protocols | 1 | 2018 | 230 | 0.130 |
Why?
|
| Education, Medical, Graduate | 2 | 1999 | 554 | 0.130 |
Why?
|
| Practice Management | 1 | 1997 | 6 | 0.130 |
Why?
|
| Linear Models | 2 | 2016 | 688 | 0.130 |
Why?
|
| Students, Medical | 1 | 2022 | 347 | 0.130 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2017 | 37 | 0.130 |
Why?
|
| Diagnosis-Related Groups | 1 | 2017 | 26 | 0.130 |
Why?
|
| Information Seeking Behavior | 1 | 2017 | 18 | 0.130 |
Why?
|
| Comorbidity | 3 | 2017 | 1595 | 0.130 |
Why?
|
| Mammography | 2 | 2015 | 122 | 0.120 |
Why?
|
| Access to Information | 1 | 2017 | 46 | 0.120 |
Why?
|
| Delivery of Health Care | 3 | 2021 | 689 | 0.120 |
Why?
|
| Healthy Lifestyle | 1 | 2016 | 33 | 0.120 |
Why?
|
| Diabetic Retinopathy | 1 | 1997 | 75 | 0.120 |
Why?
|
| Diabetic Nephropathies | 1 | 1997 | 115 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2024 | 844 | 0.120 |
Why?
|
| Medical Overuse | 1 | 2016 | 23 | 0.120 |
Why?
|
| Asymptomatic Infections | 1 | 2016 | 40 | 0.120 |
Why?
|
| Enterobius | 1 | 1996 | 2 | 0.120 |
Why?
|
| Rural Health | 1 | 1996 | 46 | 0.120 |
Why?
|
| Enterobiasis | 1 | 1996 | 4 | 0.120 |
Why?
|
| Food Supply | 1 | 2017 | 94 | 0.120 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2024 | 859 | 0.120 |
Why?
|
| Cultural Competency | 1 | 2016 | 50 | 0.120 |
Why?
|
| Accidents, Occupational | 1 | 2015 | 9 | 0.110 |
Why?
|
| Total Quality Management | 1 | 2015 | 22 | 0.110 |
Why?
|
| Industry | 1 | 2015 | 29 | 0.110 |
Why?
|
| Homocysteine | 1 | 2015 | 116 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 3 | 2013 | 1295 | 0.110 |
Why?
|
| Teaching | 1 | 1996 | 196 | 0.110 |
Why?
|
| Diabetic Foot | 1 | 1997 | 172 | 0.110 |
Why?
|
| Data Collection | 2 | 2010 | 370 | 0.110 |
Why?
|
| Contraindications | 1 | 2014 | 75 | 0.110 |
Why?
|
| Leukocytes | 1 | 2015 | 205 | 0.110 |
Why?
|
| Quality Assurance, Health Care | 1 | 1996 | 205 | 0.110 |
Why?
|
| Referral and Consultation | 2 | 2014 | 564 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 5196 | 0.100 |
Why?
|
| Diet Therapy | 1 | 2014 | 40 | 0.100 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 169 | 0.100 |
Why?
|
| Appendicitis | 1 | 1996 | 132 | 0.100 |
Why?
|
| Physical Therapy Modalities | 1 | 2014 | 51 | 0.100 |
Why?
|
| Pharyngitis | 4 | 2024 | 34 | 0.100 |
Why?
|
| Catheter-Related Infections | 1 | 2016 | 146 | 0.100 |
Why?
|
| Telomere | 1 | 2015 | 219 | 0.100 |
Why?
|
| Needs Assessment | 1 | 2015 | 173 | 0.100 |
Why?
|
| Cause of Death | 1 | 2016 | 506 | 0.100 |
Why?
|
| Southeastern United States | 1 | 2013 | 35 | 0.100 |
Why?
|
| Patient Compliance | 1 | 2017 | 463 | 0.100 |
Why?
|
| Weight Gain | 1 | 2016 | 393 | 0.100 |
Why?
|
| Internet | 1 | 2017 | 420 | 0.100 |
Why?
|
| Parenting | 1 | 2018 | 348 | 0.100 |
Why?
|
| Diabetes, Gestational | 1 | 2015 | 112 | 0.100 |
Why?
|
| Students, Nursing | 1 | 2013 | 24 | 0.100 |
Why?
|
| Veterans | 1 | 2025 | 1763 | 0.100 |
Why?
|
| Qualitative Research | 3 | 2025 | 730 | 0.100 |
Why?
|
| Asthma | 1 | 2002 | 922 | 0.100 |
Why?
|
| Mothers | 1 | 2017 | 388 | 0.100 |
Why?
|
| Prognosis | 3 | 2011 | 4886 | 0.100 |
Why?
|
| Oral Hygiene | 1 | 2013 | 9 | 0.100 |
Why?
|
| Escherichia coli | 3 | 2024 | 991 | 0.100 |
Why?
|
| Drinking | 1 | 2013 | 27 | 0.100 |
Why?
|
| Electrolytes | 1 | 2013 | 59 | 0.100 |
Why?
|
| Mutation | 1 | 2007 | 6099 | 0.100 |
Why?
|
| Automobile Driving | 1 | 2013 | 29 | 0.100 |
Why?
|
| Waist Circumference | 1 | 2013 | 94 | 0.090 |
Why?
|
| Commerce | 1 | 2013 | 58 | 0.090 |
Why?
|
| Registries | 1 | 2020 | 1634 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2018 | 12936 | 0.090 |
Why?
|
| Guideline Adherence | 3 | 2016 | 387 | 0.090 |
Why?
|
| Quality of Health Care | 1 | 2015 | 413 | 0.090 |
Why?
|
| Sports | 1 | 2013 | 68 | 0.090 |
Why?
|
| Child Abuse | 1 | 2015 | 228 | 0.090 |
Why?
|
| Pain Management | 1 | 2014 | 205 | 0.090 |
Why?
|
| Hypertension | 1 | 2000 | 1356 | 0.090 |
Why?
|
| Florida | 3 | 2015 | 73 | 0.090 |
Why?
|
| Abruptio Placentae | 1 | 2011 | 14 | 0.090 |
Why?
|
| Focus Groups | 2 | 2025 | 239 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2017 | 5063 | 0.080 |
Why?
|
| Placenta Previa | 1 | 2011 | 66 | 0.080 |
Why?
|
| Health Policy | 1 | 2013 | 234 | 0.080 |
Why?
|
| Morbidity | 1 | 2011 | 256 | 0.080 |
Why?
|
| Hyperemesis Gravidarum | 1 | 2010 | 4 | 0.080 |
Why?
|
| Premenstrual Syndrome | 1 | 2010 | 6 | 0.080 |
Why?
|
| Menstruation Disturbances | 1 | 2010 | 15 | 0.080 |
Why?
|
| DNA | 1 | 2015 | 1399 | 0.080 |
Why?
|
| Plant Preparations | 1 | 2010 | 15 | 0.080 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2010 | 30 | 0.080 |
Why?
|
| Larva | 1 | 2011 | 243 | 0.080 |
Why?
|
| Epinephrine | 1 | 2011 | 150 | 0.080 |
Why?
|
| Missouri | 4 | 2011 | 42 | 0.080 |
Why?
|
| Menopause | 1 | 2010 | 85 | 0.080 |
Why?
|
| Physician Executives | 1 | 2010 | 33 | 0.080 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2023 | 401 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 1267 | 0.070 |
Why?
|
| Attitude to Health | 2 | 2004 | 247 | 0.070 |
Why?
|
| Prenatal Care | 2 | 2009 | 345 | 0.070 |
Why?
|
| Physical Examination | 2 | 2003 | 171 | 0.070 |
Why?
|
| Infertility, Female | 1 | 2010 | 145 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2025 | 1445 | 0.070 |
Why?
|
| Physician's Role | 1 | 2010 | 164 | 0.070 |
Why?
|
| Stillbirth | 1 | 2008 | 95 | 0.060 |
Why?
|
| Health Education | 2 | 2001 | 228 | 0.060 |
Why?
|
| Poverty | 2 | 2025 | 462 | 0.060 |
Why?
|
| Heart Failure | 1 | 2000 | 2332 | 0.060 |
Why?
|
| Ethanol | 1 | 2008 | 170 | 0.060 |
Why?
|
| Fetal Growth Retardation | 1 | 2009 | 253 | 0.060 |
Why?
|
| Dietary Supplements | 1 | 2010 | 448 | 0.060 |
Why?
|
| Incidence | 2 | 2021 | 3360 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2007 | 318 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2009 | 237 | 0.060 |
Why?
|
| Analgesics | 1 | 2007 | 120 | 0.060 |
Why?
|
| Survival Rate | 1 | 2011 | 2114 | 0.060 |
Why?
|
| Age Distribution | 1 | 2007 | 422 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2007 | 352 | 0.060 |
Why?
|
| Professional Competence | 2 | 2016 | 97 | 0.060 |
Why?
|
| Urine | 1 | 2025 | 89 | 0.060 |
Why?
|
| Premature Birth | 1 | 2010 | 428 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2007 | 173 | 0.060 |
Why?
|
| Quality of Life | 1 | 2015 | 2082 | 0.060 |
Why?
|
| Common Cold | 1 | 2024 | 25 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2007 | 321 | 0.050 |
Why?
|
| Logistic Models | 3 | 2015 | 1797 | 0.050 |
Why?
|
| Employment | 1 | 2025 | 74 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2008 | 1246 | 0.050 |
Why?
|
| American Medical Association | 1 | 2004 | 6 | 0.050 |
Why?
|
| Drug Resistance, Multiple | 1 | 2024 | 57 | 0.050 |
Why?
|
| Nitrofurantoin | 1 | 2023 | 10 | 0.050 |
Why?
|
| Workplace | 1 | 2024 | 80 | 0.050 |
Why?
|
| Hyperglycemic Hyperosmolar Nonketotic Coma | 1 | 2003 | 9 | 0.050 |
Why?
|
| Health Literacy | 1 | 2024 | 77 | 0.050 |
Why?
|
| Infant | 5 | 2021 | 13352 | 0.050 |
Why?
|
| Mental Disorders | 2 | 2003 | 910 | 0.050 |
Why?
|
| Medical History Taking | 1 | 2003 | 107 | 0.050 |
Why?
|
| Fluoroquinolones | 1 | 2024 | 96 | 0.050 |
Why?
|
| Medicare | 2 | 2010 | 442 | 0.050 |
Why?
|
| Biopsy | 1 | 2007 | 1239 | 0.050 |
Why?
|
| Overweight | 2 | 2017 | 387 | 0.050 |
Why?
|
| Mexico | 1 | 2023 | 190 | 0.050 |
Why?
|
| Antimicrobial Stewardship | 1 | 2024 | 89 | 0.050 |
Why?
|
| Demography | 1 | 2024 | 237 | 0.050 |
Why?
|
| Diarrhea | 1 | 2024 | 301 | 0.050 |
Why?
|
| Triage | 1 | 2003 | 144 | 0.050 |
Why?
|
| Pharmacists | 1 | 2023 | 104 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2023 | 311 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2007 | 863 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2002 | 136 | 0.040 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2022 | 33 | 0.040 |
Why?
|
| Career Mobility | 1 | 2022 | 52 | 0.040 |
Why?
|
| Schools, Medical | 1 | 2022 | 113 | 0.040 |
Why?
|
| Hypertension, Renal | 1 | 2000 | 30 | 0.040 |
Why?
|
| Feedback | 1 | 2021 | 144 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 981 | 0.040 |
Why?
|
| Outpatients | 1 | 2022 | 262 | 0.040 |
Why?
|
| Accidents, Home | 1 | 2019 | 9 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2001 | 120 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2011 | 272 | 0.040 |
Why?
|
| Intellectual Disability | 1 | 2007 | 1089 | 0.040 |
Why?
|
| Peer Group | 1 | 2020 | 128 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2025 | 3711 | 0.040 |
Why?
|
| Maternal Age | 1 | 2019 | 136 | 0.040 |
Why?
|
| Reference Values | 1 | 2000 | 676 | 0.040 |
Why?
|
| Gestational Age | 2 | 2015 | 1224 | 0.040 |
Why?
|
| Anti-Ulcer Agents | 1 | 1999 | 140 | 0.040 |
Why?
|
| Physicians | 1 | 2025 | 635 | 0.040 |
Why?
|
| Baltimore | 1 | 2018 | 45 | 0.040 |
Why?
|
| New York City | 1 | 2018 | 59 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2022 | 281 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 1999 | 563 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 293 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 1999 | 233 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2000 | 414 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2021 | 1483 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1998 | 150 | 0.030 |
Why?
|
| Patient Selection | 1 | 2001 | 729 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2011 | 1211 | 0.030 |
Why?
|
| Consensus Development Conferences, NIH as Topic | 1 | 1996 | 3 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 1998 | 732 | 0.030 |
Why?
|
| Tonsillitis | 1 | 1996 | 13 | 0.030 |
Why?
|
| Americas | 1 | 2016 | 52 | 0.030 |
Why?
|
| Ohio | 1 | 1996 | 85 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 1996 | 81 | 0.030 |
Why?
|
| Parent-Child Relations | 1 | 2018 | 253 | 0.030 |
Why?
|
| Bronchitis | 1 | 1996 | 29 | 0.030 |
Why?
|
| Colic | 1 | 1996 | 10 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2000 | 1129 | 0.030 |
Why?
|
| Evidence-Based Nursing | 1 | 2015 | 4 | 0.030 |
Why?
|
| Nurse Administrators | 1 | 2015 | 4 | 0.030 |
Why?
|
| Medical Staff | 1 | 2015 | 6 | 0.030 |
Why?
|
| Organizational Case Studies | 1 | 2015 | 24 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2021 | 546 | 0.030 |
Why?
|
| Time Factors | 2 | 2020 | 6196 | 0.030 |
Why?
|
| Perception | 1 | 2017 | 231 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2015 | 242 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2015 | 176 | 0.030 |
Why?
|
| Bronchodilator Agents | 1 | 1996 | 158 | 0.030 |
Why?
|
| Vital Statistics | 2 | 2010 | 3 | 0.030 |
Why?
|
| Animals | 2 | 2011 | 33912 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 1996 | 254 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2010 | 761 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2015 | 231 | 0.020 |
Why?
|
| Recurrence | 1 | 2017 | 1489 | 0.020 |
Why?
|
| Minority Groups | 1 | 2015 | 260 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2013 | 143 | 0.020 |
Why?
|
| Life Style | 1 | 2015 | 456 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 423 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 2010 | 45 | 0.020 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2010 | 80 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 256 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2015 | 722 | 0.020 |
Why?
|
| Smoking Prevention | 1 | 2009 | 34 | 0.020 |
Why?
|
| Causality | 1 | 2009 | 89 | 0.020 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2009 | 63 | 0.020 |
Why?
|
| Placental Circulation | 1 | 2008 | 23 | 0.020 |
Why?
|
| Birth Weight | 1 | 2010 | 347 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 6459 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1618 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 1410 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 1680 | 0.010 |
Why?
|
| Medicaid | 2 | 1997 | 268 | 0.010 |
Why?
|
| Endocarditis | 1 | 2003 | 102 | 0.010 |
Why?
|
| Syndrome | 1 | 2003 | 1155 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 3061 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 2003 | 327 | 0.010 |
Why?
|
| HIV Infections | 1 | 2010 | 2049 | 0.010 |
Why?
|
| Kentucky | 1 | 1997 | 29 | 0.010 |
Why?
|
| Echocardiography | 1 | 2003 | 1125 | 0.010 |
Why?
|
| Rhinitis | 1 | 1997 | 43 | 0.010 |
Why?
|
| Cough | 1 | 1997 | 97 | 0.010 |
Why?
|
| Forecasting | 1 | 1997 | 351 | 0.010 |
Why?
|
| Social Class | 1 | 1997 | 214 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1997 | 928 | 0.010 |
Why?
|
| Lebanon | 1 | 1992 | 10 | 0.010 |
Why?
|
| Warfare | 1 | 1992 | 33 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1996 | 401 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 1997 | 512 | 0.010 |
Why?
|